Definition:
A nucleoside reverse transcriptase inhibitor first approved by FDA in 1995 and used in combination with other antiretroviral agents for adults, adolescents, and children.
A nucleoside reverse transcriptase inhibitor first approved by FDA in 1995 and used in combination with other antiretroviral agents for adults, adolescents, and children.
Also Known As:
3TC, Lamivudine
3TC, Lamivudine

